Cassiopea announces results of extraordinary shareholders meeting
Cassiopea S.p.A., a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, today announced the results of the extraordinary shareholders meeting held on 28 May 2020 in Lainate.